05/06/2022

Invitation for Bid: Accommodation and Transportation

INVITATION FOR BID [Accommodation and Transportation] The International Vaccine Institute (IVI) now invites sealed proposals from interested parties for the supply of the following goods and/or services: Ref. No: IVI-BDD/2022-0506 Deadline for proposal submission: 17:00 on May 19, 2022, KST(GMT + 9 h) Services to […]
05/10/2022

IVI and SK bioscience confirm SK’s COVID-19 vaccine candidate meets coprimary objectives in a joint 6-country Phase III study

Recombinant protein-based ‘SKYCovione™’ adjuvanted with GSK’s pandemic adjuvant demonstrates superior neutralizing titers compared to a control vaccine and safety SK bioscience submits a biologics license application to KMFDS, and will submit license applications to international regulatory agencies Company set to supply 10 million doses of […]
05/12/2022

New typhoid conjugate vaccine licensed in Korea

05/13/2022

IVI, KDCA exchange MOU on ROK’s state funding, strengthened cooperation